Browse > Article
http://dx.doi.org/10.5223/pghn.2015.18.2.138

Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly  

Kim, Jung Ah (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine)
Kim, Ja Hye (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine)
Lee, Beom Hee (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine)
Kim, Gu-Hwan (Medical Genetics Center, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine)
Shin, Yoon S. (University Children's Hospital and Molecular Genetics and Metabolism Laboratory)
Yoo, Han-Wook (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine)
Kim, Kyung Mo (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine)
Publication Information
Pediatric Gastroenterology, Hepatology & Nutrition / v.18, no.2, 2015 , pp. 138-143 More about this Journal
Abstract
Glycogen storage disease type IX (GSD IX) is caused by a defect in phosphorylase b kinase (PhK) that results from mutations in the PHKA2, PHKB, and PHKG2 genes. Patients usually manifest recurrent ketotic hypoglycemia with growth delay, but some may present simple hepatomegaly. Although GSD IX is one of the most common causes of GSDs, its biochemical and genetic diagnosis has been problematic due to its rarity, phenotypic overlap with other types of GSDs, and genetic heterogeneities. In our report, a 22-month-old boy with GSD IX is described. No other manifestations were evident except for hepatomegaly. His growth and development also have been proceeding normally. Diagnosed was made by histologic examination, an enzyme assay, and genetic testing with known c.3210_3212del (p.Arg1070del) mutation in PHKA2 gene.
Keywords
Glycogen storage disease; Glycogen storage disease type IX; Phosphorylase b kinase 2; Phosphorylase kinase; Hepatomegaly;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lau CK, Hui J, Fong FN, To KF, Fok TF, Tang NL, et al. Novel mutations in PHKA2 gene in glycogen storage disease type IX patients from Hong Kong, China. Mol Genet Metab 2011;102:222-5.   DOI
2 Maichele AJ, Burwinkel B, Maire I, Sovik O, Kilimann MW. Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans. Nat Genet 1996;14:337-40.   DOI
3 Newgard CB, Hwang PK, Fletterick RJ. The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol 1989;24:69-99.   DOI
4 Tsilianidis LA, Fiske LM, Siegel S, Lumpkin C, Hoyt K, Wasserstein M, et al. Aggressive therapy improves cirrhosis in glycogen storage disease type IX. Mol Genet Metab 2013;109:179-82.   DOI
5 Bali DS, Goldstein JL, Fredrickson K, Rehder C, Boney A, Austin S, et al. Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. Mol Genet Metab 2014;111:309-13.   DOI
6 Park KJ, Park HD, Lee SY, Ki CS, Choe YH. A novel PHKA2 gross deletion mutation in a Korean patient with X-linked liver glycogenosis type I. Ann Clin Lab Sci 2011;41:197-200.
7 Crushell E, Treacy EP, Dawe J, Durkie M, Beauchamp NJ. Glycogen storage disease type III in the Irish population. J Inherit Metab Dis 2010;33 Suppl 3:S215-8.   DOI
8 Choi J, Ko JM, Kim GH, Yoo HW. Clinical manifestation and effect of corn starch on height growth in Korean patients with glycogen storage disease type Ia. J Korean Soc Pediatr Endocrinol 2007;12:35-40.
9 Beauchamp NJ, Taybert J, Champion MP, Layet V, Heinz-Erian P, Dalton A, et al. High frequency of missense mutations in glycogen storage disease type VI. J Inherit Metab Dis 2007;30:722-34.   DOI
10 Moses SW, Parvari R. The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies. Curr Mol Med 2002;2:177-88.   DOI
11 Hidaka F, Sawada H, Matsuyama M, Nunoi H. A novel mutation of the PHKA2 gene in a patient with X-linked liver glycogenosis type 1. Pediatr Int 2005;47:687-90.   DOI
12 Ban HR, Kim KM, Jang JY, Kim GH, You HW, Kim K, et al. Living donor liver transplantation in a Korean child with glycogen storage disease type IV and a GBE1 mutation. Gut Liver 2009;3:60-3.   DOI
13 Brushia RJ, Walsh DA. Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure. Front Biosci 1999;4:D618-41.   DOI
14 Rudolfova J, Slovackova R, Trbusek M, Peskova K, St'astna S, Kozak L. Identification of three novel mutations in the PHKA2 gene in Czech patients with Xlinked liver glycogenosis. J Inherit Metab Dis 2001;24:85-7.   DOI
15 Bak H, Cordato D, Carey WF, Milder D. Adult-onset exercise intolerance due to phosphorylase b kinase deficiency. J Clin Neurosci 2001;8:286-7.   DOI
16 Morava E, Wortmann SB, van Essen HZ, Liebrand van Sambeek R, Wevers R, van Diggelen OP. Biochemical characteristics and increased tetraglucoside excretion in patients with phosphorylase kinase deficiency. J Inherit Metab Dis 2005;28:703-6.   DOI